Wikidata

(Q40694541)

English

Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma

scientific article published on November 1994

In more languages

Statements

title
Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
7856291
retrieved
22 September 2017
author name string
P O Livingston
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
7856291
retrieved
22 September 2017
S Adluri
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
7856291
retrieved
22 September 2017
F Helling
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
7856291
retrieved
22 September 2017
T J Yao
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
7856291
retrieved
22 September 2017
C R Kensil
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
7856291
retrieved
22 September 2017
M J Newman
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
7856291
retrieved
22 September 2017
D Marciani
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
7856291
retrieved
22 September 2017
publication date
1 November 1994
1 reference
stated in
Europe PubMed Central
PubMed ID
7856291
retrieved
22 September 2017
page(s)
1275-1280
1 reference
stated in
Europe PubMed Central
PubMed ID
7856291
retrieved
22 September 2017
issue
14
1 reference
stated in
Europe PubMed Central
PubMed ID
7856291
retrieved
22 September 2017
cites work

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40694541&oldid=2086984020"